Linda Long

*/**/****

**** ****** ***** **.

San Antonio, TX 78250

Mobile: 210-***-****

acwrcb@r.postjobfree.com

PROFESSIONAL OVERVIEW

Experienced professional with multiple degrees and an advanced technical certificate in clinical research coordination in addition to a strong background in research and medical technology.

EDUCATION

Texas A&M University San Antonio

Aug 2016

B.A.A.S.: Criminology

Presidential Award Scholarship Recipient

Summa Cum Laude

Northwest Vista College

Dec 2015

A.A.: Liberal Arts

Phi Theta Kappa Honor Society

Northwest Vista College

Aug 2015

A.A.S.: Clinical Research Coordinator

Phi Theta Kappa Honor Society

EXPERIENCE

Interim Study Coordinator Focus and Balance, LLC

August 2016 – September 2016

Organized clinical research program in a psychiatric office, facilitated monitor visits and queries, investigated subjects for recruitment through Study KIK.

Clinical Research Coordinator Intern Clinical Trials of Texas

January 2015 – May 2015

Completed 340 hours observing the clinical trial process from generating forms, randomizations and reporting of (serious) adverse events. Extensive medical data input into Real Time computer program, assisted quality control and regulatory departments with archiving records.

Senior Research Assistant UTHSCSA (Galvan Lab)

June 2013 – November 2015

Performed thin-skull window technique for two photon in vivo imaging on mice for vascular studies. Performed immune-histochemical stains and fluorescent microscopy on frozen brain sections.

Senior Research Assistant UTHSCSA (Marciniak Lab)

January 2009 – December 2012

Optimized conditions, performed qFISH, and coFISH for immuno-fluorescent studies of telomere length and orientation as well as Immuno-FISH and PNA-FISH for protein/DNA- telomere co-localization studies. Responsible for setting up and maintaining mouse colony database

Senior Research Assistant UTHSCSA (Kazhdan Lab)

July 2003 – November 2008

Conducted SDS-Page western blots to determine HER2 up-regulation of anti-apoptotic proteins survivin and Bcl2 and to characterize potentially targeted pro-apoptotic activity of tBid gene. Trained post-doctorural studentsin recombinant DNA techniques.

Senior Research Assistant UTHSCSA (Gazitt Lab)

February 2002 – March 2003

In charge of management of laboratory including safety inspections, frequent coordination with VA hospital for patient specimen handling and processing and record keeping. Determined by western blot Caspase 3 and BID activation to study apoptosis induced by arsenic trioxide (ATO).

.

SKILLS

HIPAA, CITI, IATA training, SOP and report generation, Patient triage (medical histories, phlebotomy, vital signs, ECGs, PFTs), advanced medical terminology, FDA regulatory guideline awareness, QA/QC, experience with ICH-GCP and GLP, advanced MS Office Suite knowledge, technical writing skills.

PUBLICATIONS

Modulation of telomeres in alternative lengthening of telomeres type I like human cells by the expression of Werner protein and telomerase. Siddiqa A, Cavazos D, Chavez J, Long L, Marciniak RA. J Oncol. 2012; 2012:806382. Epub 2012 Mar 28.

Expression of HER-2 in MCF-7 breast cancer cells modulates anti-apoptotic proteins Survivin and Bcl-2 via the extracellular signal-related kinase (ERK) and phosphoinositide-3 kinase (PI3K) signaling pathways. Aisha Siddiqa, Linda M Long, 1 Liuxia Li, Robert A Marciniak, Irene Kazhdan BMC Cancer. 2008; 8: 129. Published online 2008 May 2.

Targeted gene therapy for breast cancer with truncated Bid. Kazhdan I, Long L, Montellano R, Cavazos DA, Marciniak RA. Cancer Gene Ther. 2006 Feb; 13(2):141-9.

Contact this candidate